SRI-42127 is a HuR translocation inhibitor. HuR is an RNA regulator that binds to AREs, and HuR translocations promote the production of inflammatory cytokines in glial cells. However, SRI-42127 can destroy mRNA stability and inhibit gene promoter activation. SRI-42127 also inhibits microglial cell activation and attenuates recruitment/chemotaxis of neutrophils and monocytesIn VitroSRI-42127 (0.05-1 μM; 24 h) blocks HuR cytoplasmic translocation stimulated by LPS (1 μg/mL) in primary microglia. SRI-42127 (0.05-1 μM; 24 h) suppresses inflammatory cytokine and chemokine mRNA in activated Primary microglia cells (PMG). SRI-42127 (0.5 μM and 1 μM; 24 h) blocks glial-produced chemoattraction/migration signals for neutrophils and monocytes. MCE has not independently confirmed the accuracy of these methods. They are for reference only.In VivoSRI-42127 (15 mg/kg; i.p.; single dose) suppresses HuR translocation and the activation of microglia in mice model . MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:HuR.
Specifications and Purity: ≥99%
Molecular Formula: C19H20N6O
Molecular Weight: 348.40
- UPC:
- 12131508
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- S649484-25mg
- CAS:
- 2727872-68-4
- Product Size:
- 25mg
akash.verma@cenmed.com
(732) 447-1115





